Please login to the form below

Not currently logged in
Email:
Password:

European bioinformatics institute appoints GSK's Dr Andrew Leach

He joins the EMBL-EBI as head of chemistry services

EMBL EBI Dr Andrew LeachThe European Bioinformatics Institute (EBI) has appointed Dr Andrew Leach as head of chemistry services, who will take up the position on 1 September.

Dr Leach moves to the institute - a part of the European Molecular Biology Laboratory (EMBL) - from GSK Research and Development, which he joined in 1994 as a research scientist and manager.

From there, Dr Leach progressed to director of computational chemistry, Europe before taking on his most recent role as head of biomolecular sciences in which he delivered biophysics, structural biology and bioanalytical data analysis and expertise.

Between 2006 and 2015, he served as a trustee of the Cambridge Crystallographic Data Centre and was editor of the Journal of Computer-Aided Molecular Design from 1997 to 2012.

Dr Rolf Apweiler, director of EMBL-EBI, said: “Dr Leach is greatly respected in the pharma world and brings with him a wealth of knowledge and experience in drug discovery and cheminformatics.

“As a user of EMBL-EBI resources throughout his career, Andrew brings unique insights into the pharma industry's user requirements and an exciting vision for future exploitation of opportunities in data, analytics and computation.”

Dr Leach said: “I am honoured to have been chosen to take on the leadership of EMBL-EBI's highly successful chemistry services.

“I know first-hand the huge value that EMBL-EBI's resources bring to bench scientists in the industry and am looking forward to taking EMBL-EBI's chemical biology data services to the next level.”

29th March 2016

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics